AEVEX Showcases Mako Lite USV Demos and Static Displays at SOF Week 2025
TAMPA, Fla.–(BUSINESS WIRE)–AEVEX Aerospace will spotlight the cutting-edge capabilities of its Mako Lite Unmanned Surface Vehicle (USV) during SOF Week... Read more.
Hyliion to Unveil the KARNO Power Module at ACT Expo 2025
AUSTIN, Texas–(BUSINESS WIRE)–Hyliion Holdings Corp. (NYSE American: HYLN) (“Hyliion”), a developer of modular power plant technology, today announced... Read more.
Auna Announces Reporting Dates for First Quarter 2025 Financial Results
LUXEMBOURG–(BUSINESS WIRE)–Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with... Read more.
Everbridge Enhances Race-Day Safety for the 129th Running of the Boston Marathon presented by Bank of America
Marking seven years of partnership, Everbridge to once again provide critical event coordination and real-time alerts for thousands of race participants, staff,... Read more.
Kraken Launches U.S.-Listed Stock & ETF Trading, Expanding Beyond Crypto
Commission-Free Trading on 11,000+ U.S.-Listed Stocks and ETFs Now Available to Select U.S. Clients CHEYENNE, Wyo.–(BUSINESS WIRE)–Kraken, one of the... Read more.
Losartan (CAS 114798-26-4) Industry Report 2025: Global and Regional Market Trends 2019-2024 and Forecasts 2025-2029 – Manufacturers, Market Prices, Patents, Down-stream Industries – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Losartan (CAS 114798-26-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029”... Read more.
Aditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis, and Stiff Person Syndrome Human Trials
Findings Further Support the Safety Profile and Immunomodulatory Effects of ADI-100, Adimune’s Lead Therapeutic Candidate for Autoimmune Diseases MOUNTAIN VIEW,... Read more.
Wolters Kluwer CT Corporation to host webinar on effective business license management
Experts to offer insights on streamlining compliance processes and avoiding costly licensing missteps NEW YORK–(BUSINESS WIRE)–#CTcorporation–Experts... Read more.
REVEAL GENOMICS and Ona Therapeutics Join Forces to Advance Next-generation Cancer Treatment
Dr. Aleix Prat, Co-Founder and Chief Scientific Officer of REVEAL GENOMICS, identified ONA-255 drug target and currently leads the advisory board of Ona Therapeutics.... Read more.
Massive Bio Receives CNIL Certification for GDPR Compliance
BOCA RATON, Fla.–(BUSINESS WIRE)–Massive Bio holds certification from the French Data Protection Authority (CNIL), confirming its compliance with the... Read more.